Description
The prevalence of dyslipidemia in developed countries has reached epidemic proportions over the past decade. Along with this, the use of hypolipidemics has entered the broadest medical practice across many specialties, from general practitioners to specialists - cardiologists, diabetologists, and general internists. The first edition of the book Pharmacotherapy of Dyslipidemia gained deserved popularity among doctors and contributed to the introduction of new substances into therapeutic practice. The author of the book, our leading expert in the field of lipid metabolism disorders and atherosclerosis, Assoc. Prof. MUDr. Michal Vrablík, Ph.D., now presents the Second, updated edition, which responds to the rapid developments in this area. In addition to the current state, it also includes a look into the future of hypolipidemic pharmacotherapy.
Information
Author: Vrablík Michal
Language: Czech
Publication date: August 19, 2016
Manufacturer: Maxdorf s.r.o.
Genres: Health, weight loss, and sports, Medicine and healthcare, Books, Non-fiction literature, Specialized and technical literature
Type: Books - paperback
Pages: 124
ISBN/EAN: 9788073455033